Article Information
History
- December 9, 2018.
Article Versions
- Version 1 (November 16, 2018 - 08:33).
- You are currently viewing Version 2 of this article (December 9, 2018 - 22:08).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Bidesh Mahata1,2,*,
- Jhuma Pramanik1,
- Louise van der Weyden1,
- Gozde Kar2,
- Angela Riedel3,
- Nuno A. Fonseca2,
- Kousik Kundu1,
- Edward Ryder1,
- Graham Duddy1,
- Izabela Walczak1,4,
- Sarah Davidson3,
- Klaus Okkenhaug5,
- David J. Adams1,
- Jacqueline D. Shields3,* and
- Sarah A. Teichmann1,6,*
- 1Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, United Kingdom
- 2EMBL-European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SD, United Kingdom
- 3Medical Research Council Cancer Unit, Hutchison/Medical Research Council Research Centre, Cambridge, UK
- 4Iontas Ltd, Iconix Park, Cambridge, CB22 3EG, UK
- 5Division of Immunology, Department of Pathology, University of Cambridge, Cambridge, CB2 1QP UK
- 6Theory of Condensed Matter, Cavendish Laboratory, 19 JJ Thomson Ave, Cambridge, CB3 0HE, United Kingdom
- ↵*To whom correspondence should be addressed: st9{at}sanger.ac.uk, JS970{at}mrc-cu.cam.ac.uk and bm11{at}sanger.ac.uk